Clinical Evaluation of Amniotic Membrane as an Adjunct to Modified Coronally Advanced Flap and Resin-Modified Glass Ionomer Restoration in the Management of Gingival Recession Associated With Noncarious Cervical Lesions: A Randomized Split Mouth Trial.
- 1Department of Periodontology Manipal College of Dental Sciences Mangalore Manipal Academy of Higher Education Manipal India manipal.edu.
- 2Department of Oral Pathology Manipal College of Dental Sciences Mangalore Manipal Academy of Higher Education Manipal India manipal.edu.
Abstract
Introduction
Gingival recession often coexists with noncarious cervical lesions (NCCLs), complicating treatment outcomes. This study assesses the efficacy of modified coronally advanced flap (MCAF) and resin-modified glass ionomer cement (RMGIC), with or without amniotic membrane (AM), in enhancing root coverage and clinical results in gingival recession associated with NCCLs through a randomized trial.Materials and methods
A total of 15 systemically healthy patients (≥18 years), irrespective of gender, presenting with Pini-Prato et al. Class B- or B+ surface defects associated with Miller's Class I or II gingival recession, were selected. Eligible sites included maxillary posterior teeth per quadrant. A split-mouth randomized clinical trial over 6 months compared MCAF + AM + RMGIC versus MCAF + RMGIC in NCCL-associated recession. Mean standard deviation for the clinical variables was calculated for each parameter. Paired t-test was used for intragroup comparison and independent t-test for intergroup comparisons.Results
The test group consistently demonstrated superior clinical outcomes across all parameters compared to the control. Significant improvements were observed in probing depth (PD), clinical attachment level, recession width (RW), keratinized tissue height (KTH), gingival thickness (GT), and esthetic score. The use of AM adjunctively enhanced healing, root coverage, and overall treatment efficacy at 6 months.Conclusion
The combination of MCAF, RMGIC, and AM significantly enhances root coverage, esthetic outcomes, and periodontal stability. This less invasive approach offers a promising alternative to traditional techniques, warranting further investigation for long-term clinical application and protocol optimization. Trial Registration: ClinicalTrials.gov identifier: REF/2023/ 02/064206.
Related
- Evaluation of the Efficacy and Safety of Combination Therapy of Vamha and Myrha in the Management of PMOS: An Open-Label, Randomized, Multicentre, Comparative, Prospective Clinical Study
- Real-time Evaluation and Anticipation of Causal disTillation early prediction for cardiac surgery-associated acute kidney injury (REACT-01): study protocol for a single-center prospective randomized clinical trial
- Evaluation of Intraperitoneal Instillation Combined with Port-Site Infiltration of 0.5% Bupivacaine for Postoperative Pain Management in Laparoscopic Cholecystectomy: A Prospective Randomized Controlled Trial
- Posterior-anterior striatal reorganization after weight restoration in anorexia nervosa is associated with remission outcome: from mice to longitudinal human study
- Simulation-based education improves postpartum hemorrhage management knowledge and skills: a randomized controlled trial
BibTeX
@article{sanidhya2026clinical,
title = {{Clinical Evaluation of Amniotic Membrane as an Adjunct to Modified Coronally Advanced Flap and Resin-Modified Glass Ionomer Restoration in the Management of Gingival Recession Associated With Noncarious Cervical Lesions: A Randomized Split Mouth Trial.}},
author = {S Sanidhya and Deepa G Kamath and Mranali K Shetty and Aradhya Sinha and N Srikant},
journal = {International journal of dentistry},
year = {2026},
month = oct,
doi = {10.1155/ijod/1839674},
url = {https://europepmc.org/article/MED/42903270},
note = {CC BY},
}
RIS
TY - JOUR
TI - Clinical Evaluation of Amniotic Membrane as an Adjunct to Modified Coronally Advanced Flap and Resin-Modified Glass Ionomer Restoration in the Management of Gingival Recession Associated With Noncarious Cervical Lesions: A Randomized Split Mouth Trial.
AU - S Sanidhya
AU - Deepa G Kamath
AU - Mranali K Shetty
AU - Aradhya Sinha
AU - N Srikant
PY - 2026
DA - 2026/10/19
JO - International journal of dentistry
DO - 10.1155/ijod/1839674
UR - https://europepmc.org/article/MED/42903270
AB - Introduction Gingival recession often coexists with noncarious cervical lesions (NCCLs), complicating treatment outcomes. This study assesses the efficacy of modified coronally advanced flap (MCAF) and resin-modified glass ionomer cement (RMGIC), with or without amniotic membrane (AM), in enhancing root coverage and clinical results in gingival recession associated with NCCLs through a randomized trial.Materials and methods A total of 15 systemically healthy patients (≥18 years), irrespective of gender, presenting with Pini-Prato et al. Class B- or B+ surface defects associated with Miller's Class I or II gingival recession, were selected. Eligible sites included maxillary posterior teeth per quadrant. A split-mouth randomized clinical trial over 6 months compared MCAF + AM + RMGIC versus MCAF + RMGIC in NCCL-associated recession. Mean standard deviation for the clinical variables was calculated for each parameter. Paired t-test was used for intragroup comparison and independent t-test for intergroup comparisons.Results The test group consistently demonstrated superior clinical outcomes across all parameters compared to the control. Significant improvements were observed in probing depth (PD), clinical attachment level, recession width (RW), keratinized tissue height (KTH), gingival thickness (GT), and esthetic score. The use of AM adjunctively enhanced healing, root coverage, and overall treatment efficacy at 6 months.Conclusion The combination of MCAF, RMGIC, and AM significantly enhances root coverage, esthetic outcomes, and periodontal stability. This less invasive approach offers a promising alternative to traditional techniques, warranting further investigation for long-term clinical application and protocol optimization. Trial Registration: ClinicalTrials.gov identifier: REF/2023/ 02/064206.
SN - 1687-8728
SN - 1687-8736
ER -